Abstract: In populations of healthy show horses, the subclinical transmission and circulation of respiratory pathogens can lead to disease outbreaks. Due to recent outbreaks of equine herpesvirus-1 myeloencephalopathy (EHM) in the USA and Europe, many show organizers have instituted various biosecurity protocols such as individual horse testing, monitoring for early clinical disease and increasing hygiene and cleanliness protocols. The aim of this study was to determine the accuracy of detecting EHV-1 in the various environmental samples collected from the stalls of subclinical shedders. Four healthy adult horses were vaccinated intranasally with a modified-live EHV-1 vaccine in order to mimic subclinical shedding. Three additional horses served as non-vaccinated controls. All the horses were stabled in the same barn in individual stalls. Each vaccinated horse had nose-to-nose contact with at least one other horse. Prior to the vaccine administration, and daily thereafter for 10 days, various samples were collected, including a 6" rayon-tipped nasal swab, an environmental sponge, a cloth strip placed above the automatic waterer and an air sample. The various samples were processed for nucleic acid purification and analyzed for the presence of EHV-1 via quantitative PCR (qPCR). EHV-1 in nasal secretions was only detected in the vaccinated horses for 1-2 days post-vaccine administration. The environmental sponges tested EHV-1 qPCR-positive for 2-5 days (median 3.5 days) in the vaccinated horses and 1 day for a single control horse. EHV-1 was detected by qPCR in stall strips from three out of four vaccinated horses and from two out of three controls for only one day. EHV-1 qPCR-positive air samples were only detected in three out of four vaccinated horses for one single day. For the vaccinated horses, a total of 25% of the nasal swabs, 35% of the environmental stall sponges, 7.5% of the strips and 7.5% of the air samples tested qPCR positive for EHV-1 during the 10 study days. When monitoring the subclinical EHV-1 shedders, the collection and testing of the environmental sponges were able to detect EHV-1 in the environment with greater frequency as compared to nasal swabs, stationary strips and air samples.
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.
Overview
This study evaluated how well environmental samples from horse stalls can detect equine herpesvirus-1 (EHV-1) shed by horses that show no clinical symptoms.
Researchers compared different sampling methods—nasal swabs, environmental sponges, strips above waterers, and air samples—to find which was most effective in detecting EHV-1 presence in subclinical shedders.
Background
Equine herpesvirus-1 (EHV-1) is a respiratory pathogen affecting horses and can cause outbreaks in healthy show horse populations through subclinical transmission.
Recent serious outbreaks of EHV-1 myeloencephalopathy (EHM), a neurological disease caused by EHV-1, have prompted stricter biosecurity protocols at horse shows, including monitoring individual horses and enhancing hygiene.
Identifying subclinical shedders—horses shedding the virus without showing symptoms—is crucial to prevent spread, but detection can be challenging.
Study Objective
To compare the accuracy and effectiveness of various environmental sampling techniques to detect EHV-1 in the stalls of subclinical shedders.
To investigate if environmental sampling can serve as a non-invasive alternative or complement to direct nasal swab testing of horses.
Methodology
Subjects: Seven healthy adult horses were used—four were vaccinated intranasally with a modified-live EHV-1 vaccine to simulate subclinical viral shedding, and three served as unvaccinated controls.
Housing and Contact: All horses were stabled individually in the same barn; vaccinated horses had nose-to-nose contact with at least one other horse to simulate natural conditions for viral transmission.
Sampling: Samples were collected before vaccination and daily for ten days thereafter, including:
Testing: All samples were processed for nucleic acid purification and tested using quantitative PCR (qPCR) to detect EHV-1 DNA.
Key Findings
Nasal Swabs: EHV-1 was detected only briefly for 1-2 days in vaccinated horses’ nasal secretions post-vaccine, indicating short duration of detectable shedding in swabs.
Environmental Sponges: These tested positive for EHV-1 more frequently and for a longer period (2–5 days, median 3.5 days) in vaccinated horses, with one control horse also positive for 1 day, showing environmental surfaces can retain viral material longer.
Cloth Strips: EHV-1 was detected on strips from three of four vaccinated horses and two of three controls, but only for a single day, suggesting limited viral deposition on waterer areas.
Air Samples: Viral DNA was detected in the air of three vaccinated horses’ stalls, but only for one day, indicating air detection may be sporadic or less sensitive.
Overall Detection Rates in Vaccinated Horses:
25% of nasal swabs were qPCR positive
35% of environmental sponges were qPCR positive
7.5% of cloth strips were qPCR positive
7.5% of air samples were qPCR positive
Conclusions and Implications
Environmental sponges provided the most reliable detection of EHV-1 in stalls of subclinical shedders compared to other sampling methods including direct nasal swabs.
Environmental sampling offers a non-invasive, practical approach to monitor for subclinical virus shedding among horses without stressing the animals through repeated nasal swabbing.
Infection control and biosecurity protocols at horse shows could incorporate environmental sampling to detect viral presence early and prevent outbreaks caused by asymptomatic carriers.
Further studies could refine techniques and explore integration of environmental monitoring with clinical surveillance strategies to improve outbreak management.
Cite This Article
APA
Pusterla N, Lawton K, Barnum S.
(2024).
Investigation of the Use of Environmental Samples for the Detection of EHV-1 in the Stalls of Subclinical Shedders.
Viruses, 16(7), 1070.
https://doi.org/10.3390/v16071070
Silva P.G, Branco P.T.B.S, Soares R.R.G, Mesquita J.R, Sousa S.I.V. SARS-CoV-2 air sampling: A systematic review on the methodologies for detection and infectivity.. Indoor Air 2022;32:e13083.
Correia G, Rodrigues L, Afonso M, Mota M, Oliveira J, Soares R, Tomás A.L, Reichel A, Silva P.M, Costa J.J. SARS-CoV-2 air and surface contamination in residential settings.. Sci. Rep. 2022;12:18058.
Hadei M, Mohebbi S.R, Hopke P.K, Shahsavani A, Bazzazpour S, Alipour M, Jafari A.J, Bandpey A.M, Zali A, Yarahmadi M. Presence of SARS-CoV-2 in the air of public places and transportation.. Atmos. Pollut. Res. 2021;12:302–306.
da Silva P.G, Gonçalves J, Nascimento M.S.J, Sousa S.I.V, Mesquita J.R. Detection of SARS-CoV-2 in the indoor and outdoor areas of urban public transport systems of three major cities of Portugal in 2021.. Int. J. Environ. Res. Public Health 2022;19:5955.
Silva P.G.D, Nascimento M.S.J, Sousa S.I.V, Mesquita J.R. SARS-CoV-2 in outdoor air following the third wave lockdown release, Portugal, 2021.. J. Med. Microbiol. 2023;72:001659.